The number of adults worldwide with diabetes has more than doubled in the past three decades — jumping to nearly 350 million — and it continues to surge, according to a new study in the journal Lancet. Researchers say much of this dramatic increase — in Pacific island countries, North …

Results will be included in the BYDUREON™ New Drug Application Resubmission in the Third Quarter of 2011….

Outpatient electronic prescribing systems don’t cut out the common mistakes made in manual systems, suggests published research in JAMIA.…

New research from scientists in Canada has revealed that taking aspirin every day could offer benefits for those managing their diabetes….

In older women with diabetes and urinary incontinence, high A1c levels are associated with patient reports of more severe limitations due to incontinence.…

New data on the inhalable insulin product Technosphere Insulin Afrezza, from MannKind Corp., indicate that the treatment confers no discernible risk for increased cardiovascular (CV) events, while another study examined patient satisfaction with this type of drug.…

Liraglutide, recently approved in the US for the treatment of type 2 diabetes, has demonstrated its potential as a weight-loss drug for nondiabetic, obese patients.…

Zinc may perform a protective function for those with type 2 diabetes, researchers at the University of Michigan suggest….

Users of the smoking-cessation drug varenicline (Chantix) had a small but statistically significant increase in the risk of cardiovascular events, a meta-analysis of randomized trials showed.…

Impaired fasting glucose doesn’t independently increase the risk of cardiovascular events in adults, according to a large new study.…